| Literature DB >> 31269719 |
Haodong Zhu1,2,3, Chen Liu2,3,4, Jinjun Hou2,3, Huali Long2,3, Bing Wang2,3, De'an Guo2,3, Min Lei5,6, Wanying Wu7,8.
Abstract
Gastrodia elata Blume (G. elata) is a valuable Traditional Chinese Medicine (TCM) with a wide range of clinical applications. G. elata polysaccharides, as one of the main active ingredients of G. elata, have interesting extraction, purification, qualitative analysis, quantitative analysis, derivatization, and pharmacological activity aspects, yet a review of G. elata polysaccharides has not yet been published. Based on this, this article summarizes the progress of G. elata polysaccharides in terms of the above aspects to provide a basis for their further research and development.Entities:
Keywords: Gastrodia elata Bl (G. elata); pharmacological action; phytochemistry; polysaccharides
Year: 2019 PMID: 31269719 PMCID: PMC6651794 DOI: 10.3390/molecules24132436
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The extraction methods of several polysaccharides from G. elata.
| Name [ref] | Defat | Extract | Yield |
|---|---|---|---|
| WGE [ | 95% EtOH, 3 times | Boiling water, 4 times, 4 h | 5.1 g |
| AGE [ | 95% EtOH, 3 times | 5% NaOH (2 h) at 4 °C, 2 times | 10 g |
| TM [ | 95% EtOH for 7 days | Boiling water, four times, 4 h | 5.2% |
| PGEB-3H [ | 85% EtOH (1000 mL × 3) at 70 °C for 4 h | Water (800 mL × 4) at r.t. for 3 h | - |
| GR-0 [ | 10 volumes (v/w) of 80% EtOH at 60 °C, 2 times for 3 h | 2 L of boiling distilled H2O for 3 h | 2.47 g |
| RGP [ | 75% EtOH, 3 times over 24 h | Water at 74 °C, 3 times for 66 min | 6.11% |
| GPs [ | 3 volumes of absolute EtOH at 60 °C for 24 h | Water at 90 °C, 4 times at 4 h each | - |
| The crude polysaccharide [ | - | 400 mL of distilled water for 2 h at 60 °C, 3 times | 10.12% |
| GEP [ | - | Water at 90 °C for 4 h | - |
The purification methods of several polysaccharides from G. elata.
| Name [ref] | Purify | Flow Rate | Eluting Solvent | Yield |
|---|---|---|---|---|
| WGEW [ | DEAE-cellulose column (50 × 5 cm) | - | deionized water | 0.6 g from 5.1 g WGE |
| AGEW [ | DEAE-cellulose column (50 × 5 cm) | - | deionized water | 1.8 g from 10.0 g AGE |
| WTMA [ | DEAE-cellulose (50 cm × 5 cm, Cl− form) | - | 0.1M NaCl | 0.8 g from 6 g TM |
| PGEB-3H [ | DEAE-cellulose A52 column (2.6 × 30 cm) | - | deionized water | 0.797 g/kg |
| Sephadex G-100 column (1.6 × 70 cm) | - | 0.1 M NaCl | ||
| The acidic polysaccharides [ | DEAE-Sepharose CL-6B | - | 0, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 M NaCl | 0.61 g from 2.47 g GR-0 |
| RGP-1a, PGP-1b [ | DEAE-cellulose-52 column (2.6 cm × 80 cm) | 1 mL/min | deionized water | - |
| Sephadex G-100 column (1.8 cm × 100 cm) | 0.2 mL/min | deionized water | - | |
| GPs [ | DEAE-52 cellulose column | 2.0 mL/min | distilled water and a gradient of 0→2 mol/L NaCl | - |
| PGE [ | Sephadex G-200 column | 0.30 mL/min | distilled water | - |
The molecular weight, backbone, monosaccharide composition, and biological activities of polysaccharides derived from G. elata.
| Name [ref] | Molecular Weight (Da) | Monosaccharide Composition | Backbone | Biological Activities |
|---|---|---|---|---|
| WGEW [ | 1.0 × 105 | Glucose | α-1,4-glucan and α-1,4,6-glucan | - |
| AGEW [ | 2.8 × 105 | Glucose | α-1,4-glucan and α-1,4,6-glucan | - |
| WTMA [ | 7.0 × 105 | Glucose | α-1,4-glucan and α-1,4,6-glucan | Anti-cancer |
| PGEB-3 | 2.88 × 104 | Glucose | α-1,4-glucan and α-1,4,6-glucan | Cardiovascular system |
| The acidic polysaccharides [ | - | Xylose, glucose, galacturonic acid, and glucuronic acid | - | Cardiovascular system |
| RGP-1a [ | 1.925 × 104 | fructose: glucose = 1:10.68 | - | Immunological activity |
| RGP-1b [ | 3.92 × 103 | Glucose | - | Immunological activity |
| GPs [ | 2.71 × 105 | Glucose | - | Immunological activity |
| PGE [ | 1.54 × 106 | Glucose | α-1,4-glucan, α-1,3-glucan and α-1,4,6-glucan | Cardiovascular system |
| GEP [ | 875185 | Glucose | - | Antioxidant |
Figure 1Chemical structure of part of the polysaccharides derived from G. elata: x + y = R; 1. AGEW: R = 14; 2. WTMA: R = 15; 3. WGEW: R = 16; and 4. PGEB-3H: R = 20 [5].
Molecular weight, derivatization type, degree of substitution, and bioactivity of polysaccharides from G. elata and their derivatives.
| Name [ref] | Molecular Weight (Da) | Modification | DS 1 | Bioactivities 2 | ||
|---|---|---|---|---|---|---|
| a | b | c | ||||
| AGEW [ | 1.0 × 105 | - | 0 | − | − | − |
| ASS25 [ | 1.5 × 105 | sulfation | 0.579 | − | − | − |
| ASS45 [ | 6.8 × 104 | 0.624 | + | − | − | |
| WGEW [ | 2.8 × 105 | - | 0 | − | − | − |
| WSS25 [ | 6.5 × 104 | sulfation | 0.206 | + | + | + |
| WSS45 [ | 1.9 × 105 | 1.685 | + | − | − | |
| M1S [ | 1.8 × 105 | 1.050 | − | + | − | |
| M2S [ | 1.3 × 105 | 1.220 | − | + | − | |
| M3S [ | 7.5 × 104 | 1.270 | − | + | − | |
| M4S [ | 4.1 × 104 | 1.210 | − | + | − | |
| M5S [ | 1.4 × 104 | 1.050 | − | − | − | |
| M6S [ | 1.2 × 104 | 1.240 | − | − | − | |
| M7S [ | 2.7 × 103 | 1.350 | − | − | − | |
| WGES1 [ | 2.4 × 105 | 0.141 | − | + | − | |
| WGES2 [ | 6.7 × 104 | 0.097 | − | + | − | |
| WGES3 [ | 1.8 × 105 | 0.194 | − | + | − | |
| WGES4 [ | 8.0 × 104 | 0.173 | − | + | − | |
| WGES5 [ | 1.38 × 105 | 0.220 | − | + | − | |
| WGES6 [ | 7.6 × 104 | 0.202 | − | + | − | |
| WGEA | 5.7 × 103 | aminopropylation | unknown | − | − | − |
| WGEC | 7.3 × 104 | carboxymethylation | − | − | − | |
| WGEP | 2.2 × 103 | phosphorylation | − | − | − | |
| WGEL | 6.0 × 105 | acetylation | − | − | − | |
1 DS is calculated as 162 × %W/(96-80 × %W); %W is the content of SO4 2−. 2 a. Anti-dengue virus; b. antiangiogenesis; c. antiosteoporosis.
Figure 2Structures of WGEW (a) and its sulfated derivatives WSS25 and WSS45 (b) [4].
Figure 3The pathway of tube formation suppression by the sulfated polysaccharides WSS25 from G. elata.
Pharmacological activities information about polysaccharides isolated from G. elata.
| Name [ref] | Activities | Cell Lines | Animals Model | Model of Action |
|---|---|---|---|---|
| WTMA [ | anti-cancer | PANC-1, live LO2 cells | - | - |
| - | H22 tumor-bearing mice | increases caspase-3,8,9 levels and G0/G1 phase cell percentage, and decrease G2/M phase cell percentage | ||
| anti-aging and antioxidation | - | aging mice | improves the activities of SOD and GSH-Px, inhibits MAO activity, and reduces the level of MDA to | |
| - | aging mice | promote the recovery of cranial nerves, significantly improve the activity of enzymes related to oxidative metabolism in the body | ||
| GEP [ | - | aging mice | increases the activity of superoxide dismutase and glutathione peroxidase, as well as the serum and malondialdehyde levels | |
| RGP-1a, RGP-1b [ | Immunomodulatory effects | RAW 264.7 cell macrophages | - | enhances NO production and phagocytic activity |
| - | Immunocompromised mice | increases serum IgA, IgG, and hemolysin, the spleen index, thymus index, and serum IgM levels | ||
| GPs [ | - | Kunming mice | augments serum IL-2, TNF-α, IFN-γ, IgG, IgA, and IgM levels, as well as the spleen and thymus indexes | |
| PGEB-3 | - | mice | increases the Ach content in brain tissue | |
| PGB [ | BDNF-positive cells and SCF-positive cells | Focal cerebral ischemia rats | up-regulates BDNF, Nestin, and SCF expression | |
| GEP [ | neuroprotection cardiovascular system | PC12 cells | - | inhibits the endoplasmic reticulum stress-mediated pathway |
| PGB [ | - | RHR rats | promotes the production of endogenous vasoactive substances such as nitric oxide and inhibits the release of endogenous vasoconstrictors such as plasma endothelin and angiotensin II | |
| PGEB-3 | - | Hyperlipidemia rats | - | |
| Crude and acidic polysaccharides [ | cardiovascular system | - | SD rats fed a high-fat diet | suppresses total cholesterol and LDL |
| Acidic polysaccharides [ | - | SHR rats fed a high-fat diet | reduces total cholesterol, triglyceride, and LDL levels | |
| PGE [ | - | - | - |